Cancer

Explore the complexities of Cancer research and treatment in China’s pharmaceutical industry. At Fineline Info & Tech, we provide reliable data, news, and insights to enhance your understanding and decision-making. Stay informed and stay ahead in the fight against cancer with flcube.com.

Hansoh's Selective TYK2 Inhibitor HS‑10374 Hits Co‑Primary Endpoints in Pivotal Phase III Psoriasis Trial – Over Half of Patients Reach PASI 90 at Week 16
CompanyDrug

Hansoh’s Selective TYK2 Inhibitor HS‑10374 Hits Co‑Primary Endpoints in Pivotal Phase III Psoriasis Trial – Over Half of Patients Reach PASI 90 at Week 16

Hansoh Pharmaceutical Group Company Limited (HKG: 3692) announced that HS‑10374, its in‑house‑developed selective allosteric inhibitor of tyrosine kinase 2 (TYK2), met co‑primary endpoints and multiple secondary endpoints in the pivotal…

Insilico Medicine Strikes Tens‑of‑Millions‑of‑Dollars AI Collaboration with Frontier Foundation Model Lab – MMAI Gym Framework to Power Generative Biology Models

Insilico Medicine Strikes Tens‑of‑Millions‑of‑Dollars AI Collaboration with Frontier Foundation Model Lab – MMAI Gym Framework to Power Generative Biology Models

NMPA Releases 109th RLD Catalog for Chemical Generics – 30 New Product Specifications Added, 24 Supplemented

NMPA Releases 109th RLD Catalog for Chemical Generics – 30 New Product Specifications Added, 24 Supplemented

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Roche’s Tiragolumab Misses Primary Endpoints in NSCLC Trial, Study Halted

CompanyDrug

Medigene AG Secures Chinese Patent for TCR-T Therapy Targeting NY-ESO-1 and LAGE 1a

CompanyDrug

J&J’s Rybrevant Earns First-Line NSCLC Approval in Canada, a Milestone for EGFR Exon 20 Patients

CompanyDeals

Ascentage Pharma Receives USD 100 Million Option Rights Payment from Takeda

CompanyDrug

HutchMed’s Tazverik for Follicular Lymphoma Accepted for Review by China’s NMPA

CompanyDeals

CStone Pharmaceuticals Partners with Hengrui for Promotion of Ayvakit in China

CompanyDrug

Astellas Pharma’s Xtandi Secures Third Market Approval in China for Prostate Cancer Treatment

CompanyDeals

Jiangsu Vcare Pharma Partners with Geneseeq Technology to Develop Companion Diagnostic for NTRK Inhibitor

Show More